HIV-associated chronic immune activation
- PMID: 23772616
- PMCID: PMC3729961
- DOI: 10.1111/imr.12079
HIV-associated chronic immune activation
Abstract
Systemic chronic immune activation is considered today as the driving force of CD4(+) T-cell depletion and acquired immunodeficiency syndrome (AIDS). A residual chronic immune activation persists even in HIV-infected patients in which viral replication is successfully inhibited by anti-retroviral therapy, with the extent of this residual immune activation being associated with CD4(+) T-cell loss. Unfortunately, the causal link between chronic immune activation and CD4(+) T-cell loss has not been formally established. This article provides first a brief historical overview on how the perception of the causative role of immune activation has changed over the years and lists the different kinds of immune activation characteristic of human immunodeficiency virus (HIV) infection. The mechanisms proposed to explain the chronic immune activation are multiple and are enumerated here, as well as the mechanisms proposed on how chronic immune activation could lead to AIDS. In addition, we summarize the lessons learned from natural hosts that know how to 'show AIDS the door', and discuss how these studies informed the design of novel immune modulatory interventions that are currently being tested. Finally, we review the current approaches aimed at targeting chronic immune activation and evoke future perspectives.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Figures



Similar articles
-
The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection.Front Immunol. 2021 Jul 21;12:695674. doi: 10.3389/fimmu.2021.695674. eCollection 2021. Front Immunol. 2021. PMID: 34367156 Free PMC article.
-
Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.Annu Rev Immunol. 1999;17:625-56. doi: 10.1146/annurev.immunol.17.1.625. Annu Rev Immunol. 1999. PMID: 10358770 Review.
-
Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.Virology. 2000 Sep 1;274(2):255-61. doi: 10.1006/viro.2000.0479. Virology. 2000. PMID: 10964769
-
The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche.Semin Immunol. 2008 Jun;20(3):181-6. doi: 10.1016/j.smim.2008.04.002. Epub 2008 Jul 2. Semin Immunol. 2008. PMID: 18595731 Free PMC article. Review.
-
HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies.J Immunol Res. 2021 Sep 29;2021:7316456. doi: 10.1155/2021/7316456. eCollection 2021. J Immunol Res. 2021. PMID: 34631899 Free PMC article. Review.
Cited by
-
Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV.Front Immunol. 2022 Oct 28;13:1008653. doi: 10.3389/fimmu.2022.1008653. eCollection 2022. Front Immunol. 2022. PMID: 36389792 Free PMC article.
-
Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients.Front Immunol. 2018 Oct 4;9:2291. doi: 10.3389/fimmu.2018.02291. eCollection 2018. Front Immunol. 2018. PMID: 30337929 Free PMC article.
-
Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex.PLoS One. 2018 Nov 27;13(11):e0207664. doi: 10.1371/journal.pone.0207664. eCollection 2018. PLoS One. 2018. PMID: 30481211 Free PMC article.
-
Effect of HIV infection and antiretroviral therapy on immune cellular functions.JCI Insight. 2019 Jun 20;4(12):e126675. doi: 10.1172/jci.insight.126675. eCollection 2019 Jun 20. JCI Insight. 2019. PMID: 31217351 Free PMC article.
-
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.Viruses. 2018 Mar 29;10(4):157. doi: 10.3390/v10040157. Viruses. 2018. PMID: 29596334 Free PMC article. Review.
References
-
- Barré-Sinoussi F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk of acquired immunodeficiency syndrome. Science. 1983;220:868–871. - PubMed
-
- Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunology today. 1988;9:150–155. - PubMed
-
- Sheppard HW, Ascher MS, McRae B, Anderson RE, Lang W, Allain JP. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. Journal of acquired immune deficiency syndromes. 1991;4:704–712. - PubMed
-
- Giorgi JV, et al. The Multicenter AIDS Cohort Study Group CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis. 1994;170:775–781. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials